MIRABILII, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 1.092
EU - Europa 375
AS - Asia 191
SA - Sud America 3
AF - Africa 2
OC - Oceania 1
Totale 1.664
Nazione #
US - Stati Uniti d'America 1.086
IT - Italia 148
SE - Svezia 88
IN - India 64
SG - Singapore 59
CN - Cina 52
DE - Germania 29
FI - Finlandia 28
UA - Ucraina 21
RO - Romania 20
IE - Irlanda 11
GB - Regno Unito 10
BG - Bulgaria 8
CA - Canada 6
TW - Taiwan 6
TR - Turchia 5
AR - Argentina 3
DK - Danimarca 3
FR - Francia 3
JP - Giappone 3
NL - Olanda 3
AT - Austria 1
AU - Australia 1
BE - Belgio 1
ES - Italia 1
ID - Indonesia 1
TG - Togo 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.664
Città #
Fairfield 171
Chandler 126
Ashburn 73
Woodbridge 64
Wilmington 60
Seattle 59
Rome 58
Cambridge 57
Houston 56
Princeton 36
Beijing 32
Singapore 32
Dearborn 31
Plano 30
Ann Arbor 24
Lawrence 19
Millbury 17
Stockholm 17
Boston 16
San Paolo di Civitate 14
Bremen 13
Andover 11
Dublin 11
San Diego 9
Jacksonville 8
New York 8
Sofia 8
Southend 7
Cagliari 6
Hefei 6
Daan 5
Des Moines 5
Istanbul 5
Los Angeles 5
Phoenix 5
San Mateo 5
Toronto 5
Helsinki 4
Jinan 4
Mannheim 4
Norwalk 4
Bari 3
Falls Church 3
Federal 3
Kunming 3
Milan 3
Rødovre Municipality 3
Bologna 2
Bühl 2
Centrale 2
Cincinnati 2
Cori 2
Corsico 2
Dallas 2
Frankfurt am Main 2
Fremont 2
Higashimatsuyama Shi 2
Horia 2
Latina 2
Messina 2
Miami 2
Munich 2
Nanjing 2
Perugia 2
Rovagnate 2
Simi Valley 2
Trecase 2
Velletri 2
Amsterdam 1
Arnsberg 1
Barcelona 1
Belmonte Castello 1
Brussels 1
Calvisano 1
Castellana Grotte 1
Chennai 1
Chicago 1
Giarre 1
Glasgow 1
Hanoi 1
Hyderabad 1
Indiana 1
Jakarta 1
Jinhua 1
Lappeenranta 1
Las Vegas 1
Laurel 1
Lomé 1
Mentana 1
Muizenberg 1
Mumbai 1
Oberviechtach 1
Philadelphia 1
Prineville 1
Quzhou 1
Redmond 1
Santa Clara 1
Serra 1
Sulmona 1
Taipei 1
Totale 1.222
Nome #
Preclinical antileukemia activity of tramesan. A newly identified bioactive fungal metabolite 105
Metabolic reprogramming promotes myogenesis during aging 100
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia 77
Tramesan, a novel polysaccharide from trametes versicolor. structural characterization and biological effects 77
Targeting leukemia cell metabolism 76
Biological aspects of mTOR in leukemia 76
Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation 74
Targeting the leukemia cell metabolism by the CPT1a inhibition. functional pre-clinical effects in leukemias 74
A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia. case report and literature review 71
Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin 68
Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia 66
Sirt5 inhibition induces brown fat-like phenotype in 3t3-l1 preadipocytes 60
Novel Histone Deacetilase (HDAC) inhibitors: in vitro effects on leukemic cells. 57
Targeting the leukemia cell metabolism by the Carnitinepalmitoyltransferase1a (CPT1a) inhibition: functional pre-clinical effects in Acute Myeloid Leukemias. 55
The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia 54
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 53
The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia 51
Modulation of the glycolytic metabolism in acute myeloid leukemia cells 50
Proteomic signature of CD34+ cells from chronic myeloid leukemia patients 44
The phosphatidylinositol-3-kinase inhibitor BKM120 impairs proliferation and induces pro-apoptotic effects in acute myeloid leukemia 43
Proteomic profile of CD34+ cells from chronic myeloid leukemia patients and from normal donors 41
mTOR and Bcl-2 Combined Inhibition: Synergistic Effects in Acute Lymphoblastic Leukemia Cells on Proliferation and Apoptosis, Through Mcl-1 Down-regulation. 39
Targeting metabolic pathways for potential leukemia treatment 35
PI3K inhibition by BKM120 on acute myeloid leukemia: a preclinical study 34
Reprogramming Acute Lymphoblastic Leukemia cell metabolism by inhibition of Carnitine Palmitoyltransferase 1a (Cpt1a) protein. 33
Pre-clinical activity of the PI3K inhibitor BKM120 on acute myeloid leukemia 33
Proteomic signature of CD34+ progenitors from chronic-phase chronic myeloid leukemia 33
Fatty acid oxidation and metabolic targeting of leukemia cells by the CPT1 inhibitor ST1326 30
Novel Histone Deacetylase (HDAC) inhibitors: in vitro effects on leukemic cells 29
mTOR regulation of metabolism in hematologic malignancies 29
Preclinical evaluation of the PI3K inhibitor, BKM120, in acute myeloid leukemia 26
Glycolysis inhibition on acute myeloid leukemia cells 25
Modulation of glycolytic metabolism by dichloroacetate induces apoptosis in acute myeloid leukemia cells 23
Doxorubicin-induced cardiac senescence is alleviated following treatment with combined polyphenols and micronutrients through enhancement in mitophagy 18
Corrigendum: metabolic reprogramming promotes myogenesis during aging 14
Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition 5
Erratum: The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia 3
Totale 1.781
Categoria #
all - tutte 4.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020346 0 0 10 14 46 61 56 46 46 36 20 11
2020/2021135 15 15 5 13 4 5 4 20 9 25 18 2
2021/2022335 7 17 25 32 46 5 5 27 23 25 49 74
2022/2023377 78 84 13 35 40 33 6 24 34 14 13 3
2023/2024185 12 24 6 12 10 19 13 15 10 25 21 18
2024/202564 46 18 0 0 0 0 0 0 0 0 0 0
Totale 1.781